Rock Springs Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Rock Springs Capital Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,116,578	Closed	-$13.7M	–	124
2022 Q4	$13.7M	Sell	1,116,578 -89,278	-7%	-$2.13M	0.33%	66
2022 Q3	$39.6M	Buy	1,205,856 +184,697	+18%	+$5.22M	1.02%	35
2022 Q2	$19.2M	Sell	1,021,159 -10,000	-1%	-$191K	0.56%	52
2022 Q1	$18.1M	Buy	+1,031,159	New	+$21.2M	0.46%	61

Rock Springs Capital Management's CINC Position: Q1 2023 in Review

Rock Springs Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,116,578 shares — an estimated $13.7M sold.

Rock Springs Capital Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $39.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Rock Springs Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Rock Springs Capital Management sold 1,116,578 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $13.7M.
Rock Springs Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Rock Springs Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $39.6M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Rock Springs Capital Management's 13F filing for Q1 2023, filed 15 May 2023.